期刊文献+

肾小球基膜Ⅳ型胶原亚链定量分析在Alport综合征诊断中的意义 被引量:2

Quantitative analysis of type Ⅳ collagen alpha 3 and alpha 5 chain in the glomerular basement membrane in patients with Alport syndrome
下载PDF
导出
摘要  目的:通过对肾组织Ⅳ型胶原亚链免疫组化染色未见异常的Alport综合征 (AS)患者进行Ⅳ型胶原亚链构成比的定量分析,探讨不典型AS的发病机制,提高AS的诊断水平。 方法:选取临床、病理及电镜符合AS、但肾组织Ⅳ型胶原亚链染色未见异常的患者 14例,运用免疫荧光双套色法,通过激光共聚焦荧光显微镜定量分析肾小球基膜(GBM)Ⅳ型胶原中α3链、α5链的含量。并选取 4例薄基膜肾病及 10例肾活检病理诊断为轻度系膜增生性病变(MsPGN)患者的组织切片作为对照。 结果:入选的 14例患者在电镜下皆以GBM病变为主。通过定量分析GBMⅣ型胶原亚链构成比,我们发现,AS患者GBMα3链和α5链在Ⅳ型胶原总体分布中所占的比例明显减少(P<0. 05, P<0. 01vsMsPGN)。根据肾组织Ⅳ型胶原亚链构成比的不同,可以将这 14例患者分为三组:①2例患者α5链 /Ⅳ型胶原比值降低,α3链 /Ⅳ型胶原比值正常。这组患者男女各 1例,无明确家族史;②9例患者α3 /Ⅳ及α5 /Ⅳ比值同时降低。这组患者女性发病明显多于男性,家系分析显示遗传方式为X性连锁显性遗传。③3例患者α3 /Ⅳ及α5 /Ⅳ比值皆正常。这组患者男性 2例,女性 1例。家系分析显示遗传方式亦为X性连锁显性遗传。我们还发现,蛋白尿的发生与α5链 /Ⅳ型胶原比值的降低程度密切相关。 Objective:Many genotypes of mutation and different phenotypes has been described in patients with Alport syndrome(AS) characterized by changes subchains of type Ⅳ collagen along the glomerular basement membrane(GBM). And in some of the patients, staining of GBM with antibodies to collagen subchains appeared positive/normal under immunohistochemistry studies. In this study, we studied such kind of atypical AS cases by quantitatively analyzed type Ⅳ collagen alpha 3 and alpha 5 chains in GBM, as to disclose the molecular pathogenesis of the disease and to provide a new method to diagnose these atypical AS. Methodology:This study involved 14 AS patients whose diagnosis were based on clinical feature,pathologic findings and electron microscopy study. All of them were positive for routine staining of subchains of type Ⅳ collagen. Immunofluorescence double staining and confocal microscopy were used to quantitatively determine the ratio of staining signal for α3(Ⅳ) or α5(Ⅳ) to Ⅳ along GBM. Four patients with thin basement membranous nephropathy (TBMN) and ten patients with mild mesangial proliferative glomerulonephritis (MsPGN) were used as the controls. Results:The GBM defect was the prominent finding under electron microscopy. Compared to MsPGN patients in the control group, the ratio of α3(Ⅳ)or α5(Ⅳ) to Ⅳ decreased significantly( P<0 05, P<0 01 vs MsPGN). Based on the results of quantitative analysis, patients were divided into three groups: Group 1, patients with reduced α5(Ⅳ)/Ⅳ but normal α3(Ⅳ) /Ⅳ. This group included 1 male and 1 female. Neither of them had positive family history of renal diseases. Group 2, patients with simultaneously reduced α5(Ⅳ)/Ⅳ and α3(Ⅳ) /Ⅳ. This group included 3 males and 6 females. Study of family history demonstrated most of the patients were X linked. Group 3, patients with normal α5(Ⅳ)/Ⅳ and α3(Ⅳ) /Ⅳ. This group included 1females and 2 males. Study of family history demonstrated most of the patients were X linked. Furthermore, we found that the reduced α5(Ⅳ)/Ⅳ correlated with proteinuria, which reflected the severity of glomerular involvement. Unlike AS, none of four patients with TBMN had decreases of α3(Ⅳ) /Ⅳ or α5(Ⅳ) /Ⅳ. Conclusion:Although the staining of subchains of type Ⅳ collagen along the GBM in some patients with AS looked like normal, the compositions of type Ⅳ collagen had altered and characterized by the decreased ratio of α3(Ⅳ)/Ⅳ or α5(Ⅳ)/Ⅳ. By applying this quantitative analysis, a new approach is available to the diagnosis of atypical AS cases. Data of this quantitative analysis is of clinical value for future classification of the genotypes and phenotypes of AS patients, and for the prognosis of these patients.
出处 《肾脏病与透析肾移植杂志》 CAS CSCD 2005年第1期4-11,共8页 Chinese Journal of Nephrology,Dialysis & Transplantation
关键词 Ⅳ型胶原 患者 比值 构成比 诊断 GBM 肾组织 基膜 家系分析 发现 Alport syndrome type Ⅳ collagen glomerular basement membrane confocal microscopy
  • 相关文献

参考文献23

  • 1王芳,丁洁,俞礼霞,杨霁云.基底膜α(Ⅳ)链染色正常的Alport综合征基因突变特点[J].中国实用儿科杂志,2003,18(6):346-349. 被引量:12
  • 2Hudson BG, Tryggvason K, Sundaramoorthy M, et al. Alport's syndrome, Goodpasture's syndrome, and type Ⅳ collagen. N Engl J Med, 2003,348:2543.
  • 3Kashtan CE. Alport syndromes: phenotypic heterogeneity of progresive hereditary nephritis. Pediatr Nephrol, 2000, 14: 502.
  • 4Grünfeld JP. Contemporary diagnostic approach in alports syndrome.Ren Fail, 2000, 22:759.
  • 5Natio I, Kawai S, Nomura S,et al. Relationship between COL4A5 gene mutation and distribution of type Ⅳ collagen in male X-linked Alport syndrome. Kidney Int, 1996,50:304.
  • 6Jais JP, Knebelmann B, Giatras I, et al. X-linked Alport syndrome:natural history in 195 families and genotype- phenotype correlations in males. J Am Soc Nephrol, 2000,11:649.
  • 7Knebelmann B, Breillat C, Forestier L, et al. Spectrum of mutations in the COL4A5 collagen gene in X-linked Alport syndrome. Am J Hum Genet, 1996, 59:1221.
  • 8Savige J, Rana K, Tonna S, et al. Thin basement membrane nephropathy. Kidney Int, 2003, 64:1169.
  • 9Barsotti P, Muda AO, Mazzucco G, et al. Distribution of a-chains of type Ⅳ collagen in glomerular basement membranes with ultrastructural alterations suggestive of Alport syndrome. Nephrol Dial Transplant, 2001, 16:945.
  • 10Plant KE, Green PM, Vetrie D, et al. Detection ofmutations in COL4A5 in patients with Alport syndrome. Hum Mutat, 1999, 13:124.

二级参考文献10

  • 1丁洁,杨霁云,刘景城,俞礼霞.免疫荧光学方法检查皮肤组织Ⅳ型胶原α5链诊断Alport综合征[J].中华儿科杂志,1997,35(4):177-179. 被引量:33
  • 2Lemmink HH,Schroder CH,Monnens LAH,et al. The clinical spectrum of type IV collagen mutations. Hum Mut, 1997,9:477.
  • 3Yoshioka K,Hino S,Takemura T,et al. Type IV collagen α5 chain:normal distribution and abnormalities in X-linked Alport Syndrome revealed by monoclonal antibody. Am J Path, 1994,144 (5) :986.
  • 4Naito I, Kawai S, Nomura S, et al. Relationship between COL4A5 gene mutation and distribution of type IV collagen in male X-linked Alport Syndrome. Kid Intern, 1996,50 : 304.
  • 5Van Der Loop FTL, Monnesn LAH, Schroder CH, et al. Identification of COMAS defects in Alport Syndrome by immunohistochemistry of skin. Kid Inter, 1999,55 : 1217.
  • 6Mazzucco G, De Maxchi M, Minga G. Renal biopsy interpretation in Alport Syndrome. Semi Diag Path,2002,19(3) :133.
  • 7Kashtan CE. Alport Syndrome : phenotypie heterogeneity of progressive hereditary nephritis. Pediatr Nephro1,2000 ,14 :502.
  • 8Miller SA, Dykes DD, Polesky HF, et al. A simple salting out procedure for entracting DNA from human nucleated cells. Nucleic Acids Res,1988,16:1215.
  • 9丁洁,郭顺华,俞礼霞,杨霁云.用PCR SSCP方法检测中国人Alport综合征COL4A5基因突变[J].中华儿科杂志,1999,37(8):473-476. 被引量:12
  • 10王芳,丁洁,俞礼霞,杨霁云.检测皮肤成纤维细胞cDNA确定Alport综合征COL4A5基因突变[J].北京大学学报(医学版),2002,34(3):219-224. 被引量:19

共引文献11

同被引文献18

  • 1曾文,吴文成,王建荣.电镜确诊早期Alport综合征2例[J].河北医药,2004,26(12):1001-1001. 被引量:4
  • 2张宏文,王芳,丁洁.Alport综合征治疗进展[J].临床儿科杂志,2006,24(1):69-71. 被引量:10
  • 3Kashtan CE.Familial hematuric syndromes-Alport syndrome,thin glomerular basement membrane disease and Fechtner/Epstein syndromes[J].Contrib Nephrol,2001,136:79-99.
  • 4Flinter F.Alport's syndrome[J].J Med Genet,1997,34 (4):326-330.
  • 5Hudson BG.The Molecular basis of goodpasture and Alport syndromes:Beacons for the discovery of the collagen Ⅳ family[J].J Am Soc Nephrol,2004,15 (10):2514-2527.
  • 6Krichen Makni S,Kharrat M,Ben Hmida M,et al.Immunohistochemistry contribution in Alport syndrome diagnosis[J].Rev Med Interne,2005,26 (7):583-587.
  • 7Pan X,Yan J,Ren H,et al.Detection of COL4A5 gene mutations in Chinese patients with Alport's syndrome[J].Nephrol Dial Transplant,2004,19(5):1123-1128.
  • 8Jais JP,Knebelmann B,Giatras I,et al.X-linked Alport syndrome:Natural history in 195 families and genotype-phenotype correlations in males[J].J Am Soc Nephrol,2000,11 (4):649-657.
  • 9Rheault MN,Kren SM,Thielen BK,et al.Mouse model of X-linked Alport syndrome[J].J Am Soc Nephrol,2004,15(6):1466-1474.
  • 10Proesmans W,van Dyck M.Enalapril in children with Alport's syndrome[J].Pediatr Nephrol,2004,19(3):271-275.

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部